NantHealth's GPS Cancer is a comprehensive, evidence-based solution that integrates whole genome sequencing, RNA sequencing, and quantitative proteomics. By analyzing the unique molecular profile of an individual's cancer, GPS Cancer aims to provide personalized treatment options that are specifically tailored to that patient.
